FR2294445A1 - Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin - Google Patents

Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin

Info

Publication number
FR2294445A1
FR2294445A1 FR7440203A FR7440203A FR2294445A1 FR 2294445 A1 FR2294445 A1 FR 2294445A1 FR 7440203 A FR7440203 A FR 7440203A FR 7440203 A FR7440203 A FR 7440203A FR 2294445 A1 FR2294445 A1 FR 2294445A1
Authority
FR
France
Prior art keywords
antiglycolytics
glycaemia
anticoagulants
heparin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7440203A
Other languages
French (fr)
Other versions
FR2294445B3 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIMBAUD MARIE
Original Assignee
RIMBAUD MARIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIMBAUD MARIE filed Critical RIMBAUD MARIE
Priority to FR7440203A priority Critical patent/FR2294445A1/en
Priority to FR7610891A priority patent/FR2347686A1/en
Publication of FR2294445A1 publication Critical patent/FR2294445A1/en
Application granted granted Critical
Publication of FR2294445B3 publication Critical patent/FR2294445B3/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/15003—Source of blood for venous or arterial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/16—Halogen-containing compounds

Abstract

Sampling tubes for glycaema dosage are treated (for sampling 5 ml of blood) with: 40 ml of a 76 g/1 soln. of NaF and 30 ml of a 10 g/1 soln. of hepain (solns. in distilled water). The sampling tubes are treated with fine pipettes contg. each soln. and then dried at 37 degrees C. They are arranged so as to ensure even distribution of the reagents along the tube. This treatment has an antiglycolytic, anticoagulant and non-haemolysing effect.
FR7440203A 1974-12-09 1974-12-09 Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin Granted FR2294445A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7440203A FR2294445A1 (en) 1974-12-09 1974-12-09 Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin
FR7610891A FR2347686A1 (en) 1974-12-09 1976-04-05 Sample tubes for determn. of glycaemia in blood - contg. heparin anticoagulant and a low level of sodium fluoride

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7440203A FR2294445A1 (en) 1974-12-09 1974-12-09 Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin
FR7610891A FR2347686A1 (en) 1974-12-09 1976-04-05 Sample tubes for determn. of glycaemia in blood - contg. heparin anticoagulant and a low level of sodium fluoride

Publications (2)

Publication Number Publication Date
FR2294445A1 true FR2294445A1 (en) 1976-07-09
FR2294445B3 FR2294445B3 (en) 1978-06-30

Family

ID=46727664

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7440203A Granted FR2294445A1 (en) 1974-12-09 1974-12-09 Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin
FR7610891A Granted FR2347686A1 (en) 1974-12-09 1976-04-05 Sample tubes for determn. of glycaemia in blood - contg. heparin anticoagulant and a low level of sodium fluoride

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7610891A Granted FR2347686A1 (en) 1974-12-09 1976-04-05 Sample tubes for determn. of glycaemia in blood - contg. heparin anticoagulant and a low level of sodium fluoride

Country Status (1)

Country Link
FR (2) FR2294445A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6040859B2 (en) * 1977-07-27 1985-09-12 喜温 三浦 Antithrombotic artificial medical materials
JPH0687062B2 (en) * 1985-05-10 1994-11-02 株式会社京都医科学研究所 How to prevent glycolysis in blood
CN105286885A (en) * 2015-09-17 2016-02-03 安徽信灵检验医学科技有限公司 Blood collection tube applicable to medical clinical examination and manufacturing method of blood collection tube

Also Published As

Publication number Publication date
FR2347686B1 (en) 1981-02-13
FR2294445B3 (en) 1978-06-30
FR2347686A1 (en) 1977-11-04

Similar Documents

Publication Publication Date Title
IT1106148B (en) APPARATUS TO CONTROL THE CONCENTRATION OF GLUCOSE IN THE BLOOD
IT1047096B (en) MULTIPLE THINNER PURPOSE FOR USE IN BLOOD ANALYSIS THROUGH ELECTRONIC INSTRUMENTATION OF THE COULTER TYPE
IT7850154A0 (en) SEMI-SOLID AS PLASMA SOLUTIONS IMPROVEMENT IN SYSTEMS FOR GLUCOSE LADITION OR SIMILAR IN PATIENTS INTRODUCTION OF FLUID SUBSTANCES OR
FR2336622A1 (en) POROUS POLYTETRAFLUOROETHYLENE TUBING, AND PROCESS FOR PREPARATION
BE847354A (en) TANNED THROMBOCYTES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS AS DIAGNOSIS AGENTS
SE391128B (en) DIALYSIS APPARATUS, SPECIAL FOR BLOOD PURIFICATION
FR2296849A1 (en) STABLE BLOOD PLASMA, ITS PREPARATION PROCESS AND ITS APPLICATIONS
IT7921220A0 (en) PROCESS AND REAGENT FOR THE DETERMINATION OF BIOLOGICALLY ACTIVE HEPARIN IN PLASMA.
FR2276042A1 (en) NEW GUANIDINES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
IT1067019B (en) METHOD AND PROVISION FOR MEASURING THE CONCENTRATION OF LOW MOLECULAR WEIGHT COMPOUNDS IN COMPLEX MEANS, IN PARTICULAR IN MEDICAL TREATMENT
IT1020659B (en) BLOOD ANALYSIS APPARATUS
BE844504A (en) NEW GUANIDINES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
FR2290665A1 (en) BLOOD COAGULATION AND SEPARATION PROCESS
OA06951A (en) Thienopyridinone derivatives, their preparation process and their therapeutic application.
IT1116032B (en) COMPOSITION AND PROCEDURE FOR THE DETERMINATION OF THE CONCENTRATION OF GLUCOSE IN BODY FLUIDS
ATE26213T1 (en) EXTERNAL MEDICATION PREPARATION CONTAINING ADENOSIN FOR THE TREATMENT OF HERPES.
IT7920294A0 (en) DEVICE FOR THE TRANSCUTANEOUS ELECTROCHEMICAL DETERMINATION OF THE PARTIAL OXYGEN PRESSURE IN THE BLOOD.
IT1148290B (en) PROCESS AND REAGENT FOR THE PHOTOMETRIC DETERMINATION OF THE BLOOD HEMOGLOBIN CONTENT
IT1140396B (en) PROMOTING AGENT FOR BLOOD COAGULATION
FR2294445A1 (en) Antiglycolytics and anticoagulants for treating glycaemia dosage tubes - consisting of sodium fluoride and heparin
BE858356A (en) 7-ACYLAMINO-8-OXO-3-OXA-1-AZABICYCLO- (4.2.0) OCTANE-2-CARBOXYLIC ACID, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
JPS5290620A (en) Novel medicine for treating acute or chronic infection by hepatisis virus b
IT1059617B (en) IMPROVED PRE-COLORED SLIDES FOR THE BLOOD EXAMINATION
IT8123063A0 (en) METHOD TO LOWER THE LEVEL OF CHOLESTEROL IN THE BLOOD.
FR2319341A1 (en) NEW GUANIDINES OR THIOUREES, THEIR PREPARATION PROCESS AND THEIR APPLICATION

Legal Events

Date Code Title Description
ST Notification of lapse